Strict peptide length is not required for the induction of cytotoxic T lymphocyte‐mediated antiviral protection by peptide vaccination

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

1991 • 2,447 citations

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

1986 • 1,723 citations

Crystal Structures of Two Viral Peptides in Complex with Murine MHC Class I H-2K ^b

1992 • 864 citations

Identification of self peptides bound to purified HLA-B27

1991 • 844 citations

Emerging Principles for the Recognition of Peptide Antigens by MHC Class I Molecules

1992 • 730 citations

Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule

1990 • 689 citations

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1989 • 632 citations

Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro

1990 • 418 citations

Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.

1991 • 334 citations

Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes

1989 • 300 citations

Peptide selection by MHC class I molecules

1991 • 253 citations

Peptide-induced antiviral protection by cytotoxic T cells.

1991 • 238 citations

Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes.

1988 • 166 citations

In vivo induction of cytotoxic T cell response by a free synthetic peptide requires CD4+ T cell help.

1991 • 146 citations

Monitoring of solid phase peptide synthesis by an automated spectrophotometric picrate method

1975 • 141 citations

Efficiency of peptides and lipopeptides for in vivo priming of virus‐specific cytotoxic T cells

1991 • 141 citations

Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC-restricted and MHC-regulated; a model for MHC-disease associations.

1986 • 139 citations

Vaccination and protection from a lethal viral infection: Identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope

1990 • 132 citations

Peptide loading of empty major histocompatibility complex molecules on RMA‐S cells allows the induction of primary cytotoxic T lymphocyte responses

1991 • 94 citations

Priming of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides.

1991 • 88 citations

Mechanisms of induction of primary virus‐specific cytotoxic T lymphocyte responses

1992 • 49 citations

Fine peptide specificity of cytotoxic T lymphocytes directed against adenovirus-induced tumours and peptide-mhc binding

1991 • 44 citations

Treatment with monoclonal anti-CD3 antibody protects against lethal Sendai virus infection by induction of natural killer cells.

1990 • 29 citations

Immunization against polyoma tumors with synthetic peptides derived from the sequences of middle‐and large‐T antigens

1992 • 29 citations

In vivo efficacy of virus-derived peptides and virus-specific cytotoxic T lymphocytes

1991 • 19 citations